作者: Christine L. Xu , Galaxy Y. Cho , Jesse D. Sengillo , Karen S. Park , Vinit B. Mahajan
关键词:
摘要: In recent years, there has been accelerated growth of clustered regularly interspaced short palindromic repeats (CRISPR) genome surgery techniques. Genome holds promise for diseases which a cure currently does not exist. the field ophthalmology, CRISPR offers possibilities treating inherited retinal dystrophies. The retina little regenerative potential, makes treatment particularly difficult. For such conditions, methods have shown great potential therapeutic applications in animal models Much anticipation surrounds as therapeutic, clinical trials ophthalmic are expected to begin early 2018. This mini-review summarizes preclinical and current trials.